<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7542286" created="15/07/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7542286</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="nitric_oxide" sem="Inorganic_compound">Nitric oxide</term> decreases <term id="T2" lex="cytokine-induced_endothelial_activation" sem="Other"><term id="T3" lex="cytokine" sem="Protein_family_or_group">cytokine</term>-induced <term id="A1" sem="Cell_natural">endothelial</term> activation</term>.</sentence>
<event id="E1">
<type class="Negative_regulation"/>
<theme idref="E2"/>
<cause idref="T1"/>
<clue>Nitric oxide <clueType>decreases</clueType> cytokine-induced endothelial activation.</clue>
</event>
<event id="E2">
<type class="Positive_regulation"/>
<theme idref="E49"/>
<cause idref="T3"/>
<clue>Nitric oxide decreases cytokine-<clueType>induced</clueType> endothelial activation.</clue>
</event>
<event id="E49">
<type class="Physiological_process"/>
<theme idref="A1"/>
<clue>Nitric oxide decreases cytokine-induced endothelial <clueType>activation</clueType>.</clue>
</event>
<sentence id="S2"><term id="T4" lex="nitric_oxide" sem="Inorganic_compound">Nitric oxide</term> selectively reduces <term id="T5" lex="endothelial_expression" sem="Other">endothelial expression</term> of <term id="T6" lex="adhesion_molecule" sem="Protein_family_or_group">adhesion molecules</term> and <term id="T7" lex="proinflammatory_cytokine" sem="Protein_family_or_group">proinflammatory cytokines</term>.</sentence>
<event KT="Fact" id="E3">
<type class="Negative_regulation"/>
<theme idref="E5"/>
<cause idref="T4"/>
<clue>Nitric oxide selectively <clueType>reduces</clueType> endothelial expression of adhesion molecules and proinflammatory cytokines.</clue>
</event>
<event KT="Fact" id="E4">
<type class="Negative_regulation"/>
<theme idref="E6"/>
<cause idref="T4"/>
<clue>Nitric oxide selectively <clueType>reduces</clueType> endothelial expression of adhesion molecules and proinflammatory cytokines.</clue>
</event>
<event KT="Other" id="E5">
<type class="Gene_expression"/>
<theme idref="T6"/>
<clue>Nitric oxide selectively reduces <clueLoc>endothelial</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> adhesion molecules and proinflammatory cytokines.</clue>
</event>
<event KT="Other" id="E6">
<type class="Gene_expression"/>
<theme idref="T7"/>
<clue>Nitric oxide selectively reduces <clueLoc>endothelial</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> adhesion molecules and proinflammatory cytokines.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S3">To test the hypothesis that <term id="T8" lex="nitric_oxide" sem="Inorganic_compound">nitric oxide</term> (<term id="T9" lex="NO" sem="Inorganic_compound">NO</term>) limits <term id="T10" lex="endothelial_activation" sem="Other"><term id="A8" sem="Cell_natural">endothelial</term> activation</term>, we treated <term id="T11" lex="cytokine-stimulated_human_saphenous_vein_endothelial_cell" sem="Cell_cultured"><term id="A2" sem="Protein_family_or_group">cytokine</term>-stimulated human saphenous vein <term id="A3" sem="Cell_natural">endothelial cells</term></term> with several <term id="T12" lex="NO_donor" sem="Inorganic_compound"><term id="T13" lex="NO" sem="Inorganic_compound">NO</term> donors</term> and assessed their effects on the inducible expression of <term id="T14" lex="vascular_cell_adhesion_molecule-1" sem="Protein_molecule">vascular cell adhesion molecule-1</term> (<term id="T15" lex="VCAM-1" sem="Protein_molecule">VCAM-1</term>).</sentence>
<event KT="Investigation" id="E7" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="E50"/>
<cause idref="T9"/>
<clue><clueKT>To test the hypothesis</clueKT> that nitric oxide (NO) <clueType>limits</clueType> endothelial activation, we treated cytokine-stimulated human saphenous vein endothelial cells with several NO donors and assessed their effects on the inducible expression of vascular cell adhesion molecule-1 (VCAM-1).</clue>
</event>
<event KT="Other" id="E50" uncertainty="doubtful">
<type class="Physiological_process"/>
<theme idref="A8"/>
<clue>To test the hypothesis that nitric oxide (NO) limits endothelial <clueType>activation</clueType>, we treated cytokine-stimulated human saphenous vein endothelial cells with several NO donors and assessed their effects on the inducible expression of vascular cell adhesion molecule-1 (VCAM-1).</clue>
</event>
<event id="E8">
<type class="Physiological_process"/>
<theme idref="A3"/>
<cause idref="A2"/>
<clue>To test the hypothesis that nitric oxide (NO) limits endothelial activation, we treated cytokine-<clueType>stimulated</clueType> human saphenous vein endothelial cells with several NO donors and assessed their effects on the inducible expression of vascular cell adhesion molecule-1 (VCAM-1).</clue>
</event>
<event KT="Method" id="E9">
<type class="Artificial_process"/>
<theme idref="E8"/>
<theme idref="T12"/>
<clue>To test the hypothesis that nitric oxide (NO) limits endothelial activation, we <clueType>treated</clueType> cytokine-stimulated human saphenous vein endothelial cells <linkTheme>with</linkTheme> several NO donors and assessed their effects on the inducible expression of vascular cell adhesion molecule-1 (VCAM-1).</clue>
</event>
<event KT="Investigation" id="E10" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E11"/>
<cause idref="T12"/>
<clue>To test the hypothesis that nitric oxide (NO) limits endothelial activation, we treated <clueLoc>cytokine-stimulated human saphenous vein endothelial cells</clueLoc> with several NO donors and <clueKT>assessed</clueKT> their <clueType>effects</clueType> <linkTheme>on</linkTheme> the inducible expression of vascular cell adhesion molecule-1 (VCAM-1).</clue>
</event>
<event KT="Other" id="E53">
<type class="Positive_regulation"/>
<theme idref="E11"/>
<clue>To test the hypothesis that nitric oxide (NO) limits endothelial activation, we treated cytokine-stimulated human saphenous vein endothelial cells with several NO donors and assessed their effects on the <clueType>inducible</clueType> expression of vascular cell adhesion molecule-1 (VCAM-1).</clue>
</event>
<event KT="Other" id="E11">
<type class="Gene_expression"/>
<theme idref="T15"/>
<clue>To test the hypothesis that nitric oxide (NO) limits endothelial activation, we treated cytokine-stimulated human saphenous vein endothelial cells with several NO donors and assessed their effects on the inducible <clueType>expression</clueType> <linkTheme>of</linkTheme> vascular cell adhesion molecule-1 (VCAM-1).</clue>
</event>
<sentence id="S4">In a <term id="T16" lex="concentration-dependent_manner" sem="Other">concentration-dependent manner</term>, <term id="T17" lex="NO" sem="Inorganic_compound">NO</term> inhibited <term id="T18" lex="interleukin_(IL)-1_alpha-stimulated_VCAM-1_expression" sem="Other"><term id="T19" lex="interleukin_(IL)-1" sem="Protein_molecule">interleukin (IL)-1</term> <term id="A4" sem="Protein_molecule">alpha</term>-stimulated <term id="T20" lex="VCAM-1" sem="Protein_molecule">VCAM-1</term> expression</term> by 35-55% as determined by <term id="T21" lex="cell_surface_enzyme_immunoassay" sem="Other">cell surface enzyme immunoassays</term> and <term id="T22" lex="flow_cytometry" sem="Other">flow cytometry</term>.</sentence>
<event KT="Analysis" Manner="High" id="E12">
<type class="Negative_regulation"/>
<theme idref="E13"/>
<cause idref="T17"/>
<clue>In a concentration-dependent manner, NO <clueType>inhibited</clueType> interleukin (IL)-1 alpha-stimulated VCAM-1 expression <clueManner>by 35-55%</clueManner> as <clueKT>determined</clueKT> by cell surface enzyme immunoassays and flow cytometry.</clue>
</event>
<event KT="Other" id="E13">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<cause idref="T19" idref1="A4"/>
<clue>In a concentration-dependent manner, NO inhibited interleukin (IL)-1 alpha-<clueType>stimulated</clueType> VCAM-1 expression by 35-55% as determined by cell surface enzyme immunoassays and flow cytometry.</clue>
</event>
<event KT="Other" id="E14">
<type class="Gene_expression"/>
<theme idref="T20"/>
<clue>In a concentration-dependent manner, NO inhibited interleukin (IL)-1 alpha-stimulated VCAM-1 <clueType>expression</clueType> by 35-55% as determined <clueExperiment>by cell surface enzyme immunoassays and flow cytometry</clueExperiment>.</clue>
</event>
<sentence id="S5">This inhibition was paralleled by reduced <term id="T23" lex="monocyte_adhesion" sem="Other"><term id="A5" sem="Cell_natural">monocyte</term> adhesion</term> to <term id="T24" lex="endothelial_monolayer" sem="Multicellular_organism_genetically_modified">endothelial monolayers</term> in <term id="T25" lex="nonstatic_assay" sem="Other">nonstatic assays</term>, was unaffected by <term id="T26" lex="cGMP_analogue" sem="Nucleotide">cGMP analogues</term>, and was quantitatively similar after stimulation by either <term id="T27" lex="IL-1_alpha" sem="Protein_family_or_group">IL-1 alpha</term>, <term id="T28" lex="IL-1_beta" sem="Protein_molecule">IL-1 beta</term>, <term id="T29" lex="IL-4" sem="Protein_molecule">IL-4</term>, <term id="T30" lex="tumor_necrosis_factor" sem="Protein_family_or_group">tumor necrosis factor</term> (<term id="T31" lex="TNF_alpha" sem="Protein_molecule">TNF alpha</term>), or <term id="T32" lex="bacterial_lipopolysaccharide" sem="Lipid">bacterial lipopolysaccharide</term>.</sentence>
<event KT="Analysis" id="E15">
<type class="Correlation"/>
<theme idref="E12"/>
<theme idref="E16"/>
<clue><corefTheme>This inhibition</corefTheme> was <clueType><clueKT>paralleled</clueKT></clueType> <linkTheme>by</linkTheme> reduced monocyte adhesion to endothelial monolayers in nonstatic assays, was unaffected by cGMP analogues, and was quantitatively similar after stimulation by either IL-1 alpha, IL-1 beta, IL-4, tumor necrosis factor (TNF alpha), or bacterial lipopolysaccharide.</clue>
</event>
<event KT="Other" id="E16">
<type class="Negative_regulation"/>
<theme idref="E17"/>
<clue>This inhibition was paralleled by <clueType>reduced</clueType> monocyte adhesion to endothelial monolayers in nonstatic assays, was unaffected by cGMP analogues, and was quantitatively similar after stimulation by either IL-1 alpha, IL-1 beta, IL-4, tumor necrosis factor (TNF alpha), or bacterial lipopolysaccharide.</clue>
</event>
<event KT="Other" id="E17">
<type class="Cell_adhesion"/>
<theme idref="A5"/>
<theme idref="T24"/>
<clue>This inhibition was paralleled by reduced monocyte <clueType>adhesion</clueType> <linkTheme>to</linkTheme> endothelial monolayers <clueExperiment>in nonstatic assays</clueExperiment>, was unaffected by cGMP analogues, and was quantitatively similar after stimulation by either IL-1 alpha, IL-1 beta, IL-4, tumor necrosis factor (TNF alpha), or bacterial lipopolysaccharide.</clue>
<comment>NER: T24 sem mod, Other_name -&gt; Other_artificial_source</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E18">
<type class="Regulation"/>
<theme idref="E12"/>
<cause idref="T26"/>
<clue><corefTheme>This inhibition</corefTheme> was paralleled by reduced monocyte adhesion to endothelial monolayers in nonstatic assays, was <clueType><cluePolarity>unaffected</cluePolarity></clueType> <linkCause>by</linkCause> cGMP analogues, and was quantitatively similar after stimulation by either IL-1 alpha, IL-1 beta, IL-4, tumor necrosis factor (TNF alpha), or bacterial lipopolysaccharide.</clue>
<comment>NER: T26 sem mod, Other_organic_compound -&gt; Nucleotide</comment></event>
<event id="E19">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<cause idref="T27"/>
<clue>This inhibition was paralleled by reduced monocyte adhesion to endothelial monolayers in nonstatic assays, was unaffected by cGMP analogues, and was quantitatively similar after <clueType>stimulation</clueType> <linkCause>by</linkCause> either IL-1 alpha, IL-1 beta, IL-4, tumor necrosis factor (TNF alpha), or bacterial lipopolysaccharide.</clue>
<comment>NO COREFTHEME</comment></event>
<event id="E20">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<cause idref="T28"/>
<clue>This inhibition was paralleled by reduced monocyte adhesion to endothelial monolayers in nonstatic assays, was unaffected by cGMP analogues, and was quantitatively similar after <clueType>stimulation</clueType> <linkCause>by</linkCause> either IL-1 alpha, IL-1 beta, IL-4, tumor necrosis factor (TNF alpha), or bacterial lipopolysaccharide.</clue>
<comment>NO COREFTHEME</comment></event>
<event id="E21">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<cause idref="T29"/>
<clue>This inhibition was paralleled by reduced monocyte adhesion to endothelial monolayers in nonstatic assays, was unaffected by cGMP analogues, and was quantitatively similar after <clueType>stimulation</clueType> <linkCause>by</linkCause> either IL-1 alpha, IL-1 beta, IL-4, tumor necrosis factor (TNF alpha), or bacterial lipopolysaccharide.</clue>
<comment>NO COREFTHEME</comment></event>
<event id="E22">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<cause idref="T31"/>
<clue>This inhibition was paralleled by reduced monocyte adhesion to endothelial monolayers in nonstatic assays, was unaffected by cGMP analogues, and was quantitatively similar after <clueType>stimulation</clueType> <linkCause>by</linkCause> either IL-1 alpha, IL-1 beta, IL-4, tumor necrosis factor (TNF alpha), or bacterial lipopolysaccharide.</clue>
<comment>NO COREFTHEME</comment></event>
<event id="E23">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<cause idref="T32"/>
<clue>This inhibition was paralleled by reduced monocyte adhesion to endothelial monolayers in nonstatic assays, was unaffected by cGMP analogues, and was quantitatively similar after <clueType>stimulation</clueType> <linkCause>by</linkCause> either IL-1 alpha, IL-1 beta, IL-4, tumor necrosis factor (TNF alpha), or bacterial lipopolysaccharide.</clue>
<comment>NO COREFTHEME</comment></event>
<event KT="Other" id="E24">
<type class="Negative_regulation"/>
<theme idref="E19"/>
<cause idref="T17"/>
<clue>This <clueType>inhibition</clueType> was paralleled by reduced monocyte adhesion to endothelial monolayers in nonstatic assays, was unaffected by cGMP analogues, and was quantitatively similar <linkTheme>after</linkTheme> stimulation by either IL-1 alpha, IL-1 beta, IL-4, tumor necrosis factor (TNF alpha), or bacterial lipopolysaccharide.</clue>
<comment>NO COREFCAUSE</comment></event>
<event KT="Other" id="E25">
<type class="Negative_regulation"/>
<theme idref="E20"/>
<cause idref="T17"/>
<clue>This <clueType>inhibition</clueType> was paralleled by reduced monocyte adhesion to endothelial monolayers in nonstatic assays, was unaffected by cGMP analogues, and was quantitatively similar <linkTheme>after</linkTheme> stimulation by either IL-1 alpha, IL-1 beta, IL-4, tumor necrosis factor (TNF alpha), or bacterial lipopolysaccharide.</clue>
<comment>NO COREFCAUSE</comment></event>
<event KT="Other" id="E26">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<cause idref="T17"/>
<clue>This <clueType>inhibition</clueType> was paralleled by reduced monocyte adhesion to endothelial monolayers in nonstatic assays, was unaffected by cGMP analogues, and was quantitatively similar <linkTheme>after</linkTheme> stimulation by either IL-1 alpha, IL-1 beta, IL-4, tumor necrosis factor (TNF alpha), or bacterial lipopolysaccharide.</clue>
<comment>NO COREFCAUSE</comment></event>
<event KT="Other" id="E27">
<type class="Negative_regulation"/>
<theme idref="E22"/>
<cause idref="T17"/>
<clue>This <clueType>inhibition</clueType> was paralleled by reduced monocyte adhesion to endothelial monolayers in nonstatic assays, was unaffected by cGMP analogues, and was quantitatively similar <linkTheme>after</linkTheme> stimulation by either IL-1 alpha, IL-1 beta, IL-4, tumor necrosis factor (TNF alpha), or bacterial lipopolysaccharide.</clue>
<comment>NO COREFCAUSE</comment></event>
<event KT="Other" id="E28">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="T17"/>
<clue>This <clueType>inhibition</clueType> was paralleled by reduced monocyte adhesion to endothelial monolayers in nonstatic assays, was unaffected by cGMP analogues, and was quantitatively similar <linkTheme>after</linkTheme> stimulation by either IL-1 alpha, IL-1 beta, IL-4, tumor necrosis factor (TNF alpha), or bacterial lipopolysaccharide.</clue>
<comment>NO COREFCAUSE</comment></event>
<sentence id="S6"><term id="T33" lex="NO" sem="Inorganic_compound">NO</term> also decreased the <term id="T34" lex="endothelial_expression" sem="Other">endothelial expression</term> of other <term id="T35" lex="leukocyte_adhesion_molecule" sem="Protein_family_or_group">leukocyte <term id="T36" lex="adhesion_molecule" sem="Protein_family_or_group">adhesion molecules</term></term> (<term id="T37" lex="E-selectin" sem="Protein_molecule">E-selectin</term> and to a lesser extent, <term id="T38" lex="intercellular_adhesion_molecule-1" sem="Protein_molecule">intercellular adhesion molecule-1</term>) and secretable <term id="T39" lex="cytokine" sem="Protein_family_or_group">cytokines</term> (<term id="T40" lex="IL-6" sem="Protein_molecule">IL-6</term> and <term id="T41" lex="IL-8" sem="Protein_molecule">IL-8</term>).</sentence>
<event id="E29">
<type class="Negative_regulation"/>
<theme idref="E33"/>
<cause idref="T33"/>
<clue>NO also <clueType>decreased</clueType> the endothelial expression of other leukocyte adhesion molecules (E-selectin and to a lesser extent, intercellular adhesion molecule-1) and secretable cytokines (IL-6 and IL-8).</clue>
</event>
<event id="E30">
<type class="Negative_regulation"/>
<theme idref="E34"/>
<cause idref="T33"/>
<clue>NO also <clueType>decreased</clueType> the endothelial expression of other leukocyte adhesion molecules (E-selectin and to a lesser extent, intercellular adhesion molecule-1) and secretable cytokines (IL-6 and IL-8).</clue>
</event>
<event id="E31">
<type class="Negative_regulation"/>
<theme idref="E35"/>
<cause idref="T33"/>
<clue>NO also <clueType>decreased</clueType> the endothelial expression of other leukocyte adhesion molecules (E-selectin and to a lesser extent, intercellular adhesion molecule-1) and secretable cytokines (IL-6 and IL-8).</clue>
</event>
<event id="E32">
<type class="Negative_regulation"/>
<theme idref="E36"/>
<cause idref="T33"/>
<clue>NO also <clueType>decreased</clueType> the endothelial expression of other leukocyte adhesion molecules (E-selectin and to a lesser extent, intercellular adhesion molecule-1) and secretable cytokines (IL-6 and IL-8).</clue>
</event>
<event id="E33">
<type class="Gene_expression"/>
<theme idref="T37"/>
<clue>NO also decreased the <clueLoc>endothelial</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> other leukocyte adhesion molecules (E-selectin and to a lesser extent, intercellular adhesion molecule-1) and secretable cytokines (IL-6 and IL-8).</clue>
</event>
<event id="E34">
<type class="Gene_expression"/>
<theme idref="T38"/>
<clue>NO also decreased the <clueLoc>endothelial</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> other leukocyte adhesion molecules (E-selectin and to a lesser extent, intercellular adhesion molecule-1) and secretable cytokines (IL-6 and IL-8).</clue>
</event>
<event id="E35">
<type class="Gene_expression"/>
<theme idref="T40"/>
<clue>NO also decreased the <clueLoc>endothelial</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> other leukocyte adhesion molecules (E-selectin and to a lesser extent, intercellular adhesion molecule-1) and secretable cytokines (IL-6 and IL-8).</clue>
</event>
<event id="E36">
<type class="Gene_expression"/>
<theme idref="T41"/>
<clue>NO also decreased the <clueLoc>endothelial</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> other leukocyte adhesion molecules (E-selectin and to a lesser extent, intercellular adhesion molecule-1) and secretable cytokines (IL-6 and IL-8).</clue>
</event>
<sentence id="S7">Inhibition of endogenous <term id="T42" lex="NO" sem="Inorganic_compound">NO</term> production by <term id="T43" lex="L-N-monomethyl-arginine" sem="Amino_acid_monomer">L-N-monomethyl-arginine</term> also induced the expression of <term id="T44" lex="VCAM-1" sem="Protein_molecule">VCAM-1</term>, but did not augment <term id="T45" lex="cytokine-induced_VCAM-1_expression" sem="Other"><term id="A6" sem="Protein_family_or_group">cytokine</term>-induced <term id="T46" lex="VCAM-1" sem="Protein_molecule">VCAM-1</term> expression</term>.</sentence>
<event id="E37">
<type class="Negative_regulation"/>
<theme idref="E38"/>
<cause idref="T43"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> endogenous NO production <linkCause>by</linkCause> L-N-monomethyl-arginine also induced the expression of VCAM-1, but did not augment cytokine-induced VCAM-1 expression.</clue>
</event>
<event KT="Other" id="E38">
<type class="Metabolism"/>
<theme idref="T42"/>
<clue>Inhibition of endogenous NO <clueType>production</clueType> by L-N-monomethyl-arginine also induced the expression of VCAM-1, but did not augment cytokine-induced VCAM-1 expression.</clue>
</event>
<event id="E39">
<type class="Positive_regulation"/>
<theme idref="E40"/>
<cause idref="E37"/>
<clue>Inhibition of endogenous NO production by L-N-monomethyl-arginine also <clueType>induced</clueType> the expression of VCAM-1, but did not augment cytokine-induced VCAM-1 expression.</clue>
</event>
<event id="E40">
<type class="Gene_expression"/>
<theme idref="T44"/>
<clue>Inhibition of endogenous NO production by L-N-monomethyl-arginine also induced the <clueType>expression</clueType> <linkTheme>of</linkTheme> VCAM-1, but did not augment cytokine-induced VCAM-1 expression.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E41">
<type class="Positive_regulation"/>
<theme idref="E42"/>
<cause idref="E37"/>
<clue>Inhibition of endogenous NO production by L-N-monomethyl-arginine also induced the expression of VCAM-1, but did <cluePolarity>not</cluePolarity> <clueType>augment</clueType> cytokine-induced VCAM-1 expression.</clue>
</event>
<event id="E42">
<type class="Positive_regulation"/>
<theme idref="E43"/>
<cause idref="A6"/>
<clue>Inhibition of endogenous NO production by L-N-monomethyl-arginine also induced the expression of VCAM-1, but did not augment cytokine-<clueType>induced</clueType> VCAM-1 expression.</clue>
</event>
<event id="E43">
<type class="Gene_expression"/>
<theme idref="T46"/>
<clue>Inhibition of endogenous NO production by L-N-monomethyl-arginine also induced the expression of VCAM-1, but did not augment cytokine-induced VCAM-1 <clueType>expression</clueType>.</clue>
</event>
<sentence id="S8"><term id="T47" lex="nuclear_run-on_assay" sem="Other">Nuclear run-on assays</term>, <term id="T48" lex="transfection_study" sem="Other">transfection studies</term> using various <term id="T49" lex="VCAM-1_promoter_reporter_gene_construct" sem="DNA_domain_or_region"><term id="T50" lex="VCAM-1" sem="Protein_molecule">VCAM-1</term> promoter <term id="T51" lex="reporter_gene_construct" sem="DNA_family_or_group">reporter gene constructs</term></term>, and <term id="T52" lex="electrophoretic_mobility_shift_assay" sem="Other">electrophoretic mobility shift assays</term> indicated that <term id="T53" lex="NO" sem="Inorganic_compound">NO</term> represses <term id="T54" lex="VCAM-1_gene_transcription" sem="Other"><term id="A11" sem="DNA_domain_or_region"><term id="T55" lex="VCAM-1" sem="Protein_molecule">VCAM-1</term> gene</term> transcription</term>, in part, by inhibiting <term id="T56" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term>.</sentence>
<event CL="L2" KT="Analysis" id="E44">
<type class="Negative_regulation"/>
<theme idref="E45"/>
<cause idref="E46"/>
<clue><clueExperiment>Nuclear run-on assays, transfection studies using various VCAM-1 promoter reporter gene constructs, and electrophoretic mobility shift assays</clueExperiment> <clueKT><clueCL>indicated</clueCL></clueKT> that NO <clueType>represses</clueType> VCAM-1 gene transcription, in part, <linkCause>by</linkCause> inhibiting NF-kappa B.</clue>
</event>
<event KT="Other" id="E45">
<type class="Transcription"/>
<theme idref="A11"/>
<clue>Nuclear run-on assays, transfection studies using various VCAM-1 promoter reporter gene constructs, and electrophoretic mobility shift assays indicated that NO represses VCAM-1 gene <clueType>transcription</clueType>, in part, by inhibiting NF-kappa B.</clue>
</event>
<event KT="Other" id="E46">
<type class="Negative_regulation"/>
<theme idref="T56"/>
<cause idref="T53"/>
<clue>Nuclear run-on assays, transfection studies using various VCAM-1 promoter reporter gene constructs, and electrophoretic mobility shift assays indicated that NO represses VCAM-1 gene transcription, in part, by <clueType>inhibiting</clueType> NF-kappa B.</clue>
</event>
<sentence id="S9">We propose that <term id="T57" lex="NO" sem="Inorganic_compound">NO</term>&apos;s ability to limit <term id="T58" lex="endothelial_activation" sem="Other"><term id="A9" sem="Cell_natural">endothelial</term> activation</term> and inhibit <term id="T59" lex="monocyte_adhesion" sem="Other"><term id="A10" sem="Cell_natural">monocyte</term> adhesion</term> may contribute to some of its <cons id="T60" lex="(AND antiatherogenic_property antiinflammatory_property)" sem="(AND Other Other)"><frag id="F1">antiatherogenic</frag> and <frag id="F2">antiinflammatory</frag> <frag id="F3">properties</frag></cons> within the <term id="T61" lex="vessel_wall" sem="Tissue_natural">vessel wall</term>.</sentence>
<event CL="L2" KT="Analysis" id="E47" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="E51"/>
<cause idref="T57"/>
<clue>We propose that NO&apos;s <clueKT><clueCL>ability to</clueCL></clueKT> <clueType>limit</clueType> endothelial activation and inhibit monocyte adhesion may contribute to some of its antiatherogenic and antiinflammatory properties within the vessel wall.</clue>
</event>
<event CL="L2" KT="Analysis" id="E48" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="E52"/>
<cause idref="T57"/>
<clue>We propose that NO&apos;s <clueKT><clueCL>ability to</clueCL></clueKT> limit endothelial activation and <clueType>inhibit</clueType> monocyte adhesion may contribute to some of its antiatherogenic and antiinflammatory properties within the vessel wall.</clue>
</event>
<event KT="Other" id="E51">
<type class="Physiological_process"/>
<theme idref="A9"/>
<clue>We propose that NO&apos;s ability to limit endothelial <clueType>activation</clueType> and inhibit monocyte adhesion may contribute to some of its antiatherogenic and antiinflammatory properties within the vessel wall.</clue>
</event>
<event KT="Other" id="E52">
<type class="Cell_adhesion"/>
<theme idref="A10"/>
<clue>We propose that NO&apos;s ability to limit endothelial activation and inhibit monocyte <clueType>adhesion</clueType> may contribute to some of its antiatherogenic and antiinflammatory properties within the vessel wall.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
